scholarly journals 0901 Dose-Response Relationship Between Insufficient Sleep and Mental Health Symptoms in Collegiate Student Athletes and Non-Athletes

SLEEP ◽  
2019 ◽  
Vol 42 (Supplement_1) ◽  
pp. A362-A362
Author(s):  
Thea Ramsey ◽  
Amy Athey ◽  
Jason Ellis ◽  
Andrew Tubbs ◽  
Robert Turner ◽  
...  
2017 ◽  
Vol 41 (S1) ◽  
pp. s130-s131
Author(s):  
F. Jörg ◽  
D. Raven ◽  
E. Visser ◽  
R. Schoevers ◽  
T. Oldehinkel

IntroductionMultidisciplinary guidelines in adolescent mental health care are based on RCTs, while treatment efficacy can be different from effectiveness seen in ‘the real world’. Studies in the real world conducted so far suggest that treatment has a negligible effect on follow-up symptomatology. However, these studies did not incorporate the pre-treatment trajectory of symptoms nor investigated a dose-response relationship.ObjectivesTo test whether future treatment users and non-users differed in emotional and behavioural problem scores, whether specialist mental health treatment (SMHT) was effective in reducing problem levels while controlling for pre-treatment trajectory, and to seek evidence of a dose-response relationship.MethodsSix-year follow up data were used from the Tracking Adolescents’ Individual Lives Survey (TRAILS). We identified adolescents with a clinical level of problem behaviour on the Child Behaviour Checklist or Youth Self Report and first SMHT between the ages 13 and 16. Adolescents with a clinical level of problem behaviour but without SMHT use served as control group. A psychiatric case register provided data on number of treatment contacts. Using regression analysis, we predicted the effect of treatment on post-treatment problem scores.ResultsTreated adolescents more often had a (severe) diagnosis than untreated adolescents. Pre-treatment trajectories barely differed between treated and untreated adolescents. Treatment predicted an increase in follow-up problem scores, regardless of the number of sessions.ConclusionThe quasi-experimental design calls for modest conclusions. We might however need to take a closer look at real-world service delivery, and invest in developing treatments that can achieve sustainable benefits.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2013 ◽  
Author(s):  
Bryann Debeer ◽  
Sandra B. Morissette ◽  
Nathan A. Kimbrel ◽  
Eric C. Meyer ◽  
Suzy B. Gulliver

2020 ◽  
Vol 26 (4) ◽  
pp. 370-387 ◽  
Author(s):  
Shannon L. Wagner ◽  
Nicole White ◽  
Cheryl Regehr ◽  
Marc White ◽  
Lynn E. Alden ◽  
...  

1962 ◽  
Vol 41 (2) ◽  
pp. 268-273 ◽  
Author(s):  
Ralph I. Dorfman

ABSTRACT The stimulating action of testosterone on the chick's comb can be inhibited by the subcutaneous injection of 0.1 mg of norethisterone or Ro 2-7239 (2-acetyl-7-oxo-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthrene), 0.5 mg of cortisol or progesterone, and by 4.5 mg of Mer-25 (1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol). No dose response relationship could be established. Norethisterone was the most active anti-androgen by this test.


Sign in / Sign up

Export Citation Format

Share Document